Evidence map›Paper›PMID 31595786›Full record

Trial reportAmyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis2020

The utility of repeat kidney biopsy in systemic immunoglobulin light chain amyloidosis.

Avital Angel-Korman, Aala Jaberi, Vaishali Sanchorawala, Andrea Havasi

Open access · greenAbstract readClinical TrialVideo-Audio Media
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Avital Angel-KormanRenal Section, Department of Medicine, Boston Medical Center, Boston, MA, USA.
Aala JaberiRenal Section, Department of Medicine, Boston Medical Center, Boston, MA, USA.
Vaishali SanchorawalaSection of Hematology and Oncology, Department of Medicine, Boston Medical Center, Boston, MA, USA.ORCID http://orcid.org/0000-0002-6307-2445
Andrea HavasiRenal Section, Department of Medicine, Boston Medical Center, Boston, MA, USA.ORCID http://orcid.org/0000-0002-8758-0823
Boston Medical Center · USBoston University · US

Funding

Proteinuria causes progressive kidney disease by impairing autophagyK08DK090143 · NIDDK · BOSTON MEDICAL CENTER · PI HAVASI, ANDREA · 2011 to 2015
$746k
NIDDK NIH HHS K08 DK090143
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Immunoglobulin Light-chain AmyloidosisPlaque, AmyloidProteinuriaAdultAgedBiopsyFemaleHumansImmunoglobulin Light ChainsKidneyMaleMiddle AgedRetrospective StudiesImmunoglobulin Light ChainsAL amyloidosiskidney biopsyrenal amyloidosisrepeat biopsySystemic light chain amyloidosis

Identifiers

PMID31595786
PMCPMC6960349
OpenAlexW2980137183

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.